565P - Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with Bev-Based Therapy: Overall Survival Subgroup Findings from ML18147
de Prado, J.M. Vieitez, Borg, C., Arnold, D., Greil, R., Van Cutsem, E.J.D., von Moos, R., Bennouna, J., Reyes-Rivera, I., Bendahmane, B., Kubicka, S.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with Bev-Based Therapy: Overall Survival Subgroup Findings from ML18147
de Prado, J.M. Vieitez, Borg, C., Arnold, D., Greil, R., Van Cutsem, E.J.D., von Moos, R., Bennouna, J., Reyes-Rivera, I., Bendahmane, B., Kubicka, S.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
571P - Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with First-Line BEV + CT (ML18147): Efficacy and Safety Analyses by Oxaliplatin vs Irinotecan-Based CT
Österlund, P., Alonso-Orduna, V., Schlichting, C., André, T., Sastre, J., Greil, R., Kubicka, S., Reyes-Rivera, I., McCall, B., Van Cutsem, E.J.D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with First-Line BEV + CT (ML18147): Efficacy and Safety Analyses by Oxaliplatin vs Irinotecan-Based CT
Österlund, P., Alonso-Orduna, V., Schlichting, C., André, T., Sastre, J., Greil, R., Kubicka, S., Reyes-Rivera, I., McCall, B., Van Cutsem, E.J.D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Adjuvant Folfox4 with or without Cetuximab (CTX) in Patients (PTS) with Resected Stage III Colon Cancer (CC): Dfs and OS Results and Subgroup Analyses of the PETACC8 Intergroup Phase III Trial
Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J., Thaler, J., Bridgewater, J.A., Van Cutsem, E.J.D., Rougier, P., Collette, L., Praet, M., Schneider, M., Bouché, O., Lepage, C., Girault, C., Emile, J.F., Laurent-Puig, P., Bedenne, L.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (MCRC): Overall Survival Update
Van Cutsem, E.J.D., Grothey, A., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouche, O., Mineur, L., Barone, C., Adenis, A., Tabernero, J., Yoshino, T., Lenz, H.-J., Goldberg, R., Sargent, D.J., Cihon, F., Cupit, L., Wagner, A., Laurent, D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article